Jeffrey J. Hessekiel, J.D., serves as the Executive Vice President, General Counsel, and Secretary at Exelixis, Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of new medicines to treat cancer. In his role, Hessekiel is responsible for overseeing the company's legal affairs, ensuring compliance with regulatory requirements, and providing strategic guidance to the executive team. His leadership has been instrumental in navigating the complex legal landscape of the pharmaceutical industry, helping Exelixis to advance its mission of improving patient outcomes. Prior to joining Exelixis, Hessekiel amassed a wealth of experience in the legal field, particularly in the life sciences sector. He holds a Juris Doctor degree and has worked with several prominent law firms, where he specialized in intellectual property, corporate governance, and securities law. His expertise in these areas has been crucial in protecting Exelixis' innovations and supporting its growth. Hessekiel's strategic approach to legal challenges has earned him a reputation as a trusted advisor and a key contributor to the company's success. Under Hessekiel's guidance, Exelixis has successfully managed numerous legal and regulatory challenges, enabling the company to focus on its core mission of developing innovative cancer treatments. His role extends beyond traditional legal duties, as he actively participates in strategic planning and decision-making processes at the executive level. Hessekiel's dedication to excellence and his ability to anticipate and mitigate legal risks have made him an invaluable asset to Exelixis, reinforcing the company's position as a leader in the biopharmaceutical industry.